Skip to main content
AQST logo

AQST · Aquestive Therapeutics, Inc. · Analyst Estimates

Track AQST — free
$4.60 +0.05 (+1.10%)
Market Cap
$584.88M
Shares
125.51M
Volume · Oct 5 1.09M Avg daily vol (3M) 2.66M

Analyst Estimates

Compare analyst forecasts for Aquestive Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 12:29 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.45
-0.45
-0.45
—
-0.42
-0.42
-0.42
-0.46
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
1
1
1
1
Revenue
USD
Publication date not stated
49175000
49928780
52100000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
9
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.7
-0.57
-0.44
—
-0.45
-0.45
-0.45
-0.58
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
52200000
67768890
112000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
9
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.15
-0.135
-0.12
—
-0.12
-0.12
-0.12
-0.11
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
2
2
0
0
Revenue
USD
Publication date not stated
9940000
11017000
11600000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
9
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.15
-0.14
-0.13
—
-0.125
-0.125
-0.125
-0.105
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
2
2
0
0
Revenue
USD
Publication date not stated
9600000
10634560
12200000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
9
— — — — — — — —
Key facts CIK 1398733 CUSIP 03843E104 13F (30d) 2 filings 2 filers Visit website Investor relations